With the progression of congestive heart failure, therapeutic options become fewer, and cardiac transplantation is the final option. The use of a left ventricular assist device improves the survival rate and quality of life in patients on the waiting list for transplantation. A 64-year-old man was successfully maintained on mechanical circulatory support with a left ventricular assist device for 502 days, as a bridge to transplantation.
Get full access to this article
View all access options for this article.
References
1.
SalzbergSLachatMZundGOechslinESchmidERDeBakeyM. Left ventricular assist device as bridge to heart transplantation-lessons learned with the MicroMed DeBakey axial blood flow pump. Eur J Cardiothorac Surg2003; 24: 113–8.
2.
FrazierOHRoseEAMcCarthyPBurtonNATectorALevinH. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg1995; 222: 327–38.
3.
PoirierVL. Worldwide experience with the TCI HeartMate system: issues and future perspective. Thorac Cardiovasc Surg1999; 47 Suppl 2:316–20.
4.
FrazierOH. Long-term mechanical circulatory support. EdmundsLHJr, editor. Cardiac surgery in the adult. 1st ed.Pennsylvania: McGraw-Hill. 1997;1477–90.
5.
VitaliELanfranconiMBruschiGRiberaEGarattiAColomboT. Mechanical circulatory support in severe heart failure: single-center experience. Transplant Proc2004; 36: 620–2.
6.
AaronsonKDPatelHPaganiFD. Patient selection for left ventricular assist device therapy. Ann Thorac Surg2003; 75 (6 Suppl): S29–35.
7.
MillerLW. Patient selection for the use of ventricular assist devices as a bridge to transplantation. Ann Thorac Surg2003; 75 (6 Suppl): S66–71.
